This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Raised serum ferritin

Authoring team

  • raised serum ferritin (SF)
    • only 10% of cases of elevated SF are due to iron overload - chronic alcohol consumption, metabolic syndrome, obesity, diabetes, malignancy, infection and inflammatory conditions explain 90% of causes of elevated SF
      • there is a well-established link between elevated SF, metabolic syndrome and fatty liver
      • liver disease is a cause of elevated SF
        • damaged hepatocytes leak ferritin into the serum
          • in liver disease, SF can be considered as another type of liver function test (LFT)

    • assessment of raised serum ferritin
      • repeat serum ferritin (SF)
        • if repeat SF > 1000 µg/L then specialist referral
        • if less than 1000 µg/L then exclude hereditary haemochromatosis
          • transferrin (TIBC)
          • genetic testing should be carried out in patients with symptoms and serum iron parameters suggestive of haemochromatosis
          • if the diagnosis of haemochromatosis is still uncertain (after blood analysis and genetic testing) consider
            • magnetic resonance imaging provides a quantitative imaging technique for the detection of iron in the liver
            • liver biopsy is an alternative if facilities for MRI is not available concentration of iron deposits can be measured
      • as well as exclusion of hereditary haemochromatosis, investigation of elevated serum ferritin involves identifying alcohol consumption, metabolic syndrome, obesity, diabetes, liver disease, malignancy, infection or inflammation as causative factors
        • conditions such as malignancy, infection and inflammatory conditions may all cause elevated SF
          • normal screening tests for C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and antinuclear antibody (ANA) can help exclude the presence of these conditions
        • suggested investigations for liver disease include:
          • liver function tests (LFTs)
          • inflammatory markers, such as C-reactive protein, erythrocyte sedimentation rate or plasma viscosity
          • hepatitis B surface antigen (HBsAg)
          • hepatitis C virus antibody (HCV-Ab)
          • antinuclear antibodies (ANA)
          • antimitochondrial antibodies (AMA)
          • anti-smooth muscle antibodies (SMA)
          • alpha-1 antitrypsin (AAT)
          • copper
          • caeruloplasmin
          • screen for metabolic syndrome, obesity, diabetes
          • assess alcohol intake
          • liver ultrasound scan. Abdominal ultrasonography may demonstrate an echogenic liver suggesting alcohol- or non-alcohol-related fatty liver disease. In such cases non-invasive fibrosis assessment is indicated using transient elastography (Fibroscan®)
    • elevations of SF in the range 300-1000 µg/L are common, and often reflect the presence of the previously listed conditions such as diabetes, obesity or chronic alcohol consumption
      • mild elevations below 1000 µg/L are 'tolerable' and in the absence of hereditary haemochromatosis, the risk of hepatic iron overload is exceedingly low

    • referral criteria from primary care
      • specialist review is mandatory if SF exceeds 1000 µg/L due to the increased risk of fibrosis and cirrhosis above this threshold
        • referral to a gastroenterologist, haematologist or physician with an interest in iron overload is appropriate if serum ferritin is >1000 µg/L or
          • if the cause of elevated serum ferritin is still unclear

Reference:

  1. Cullis J et al. Investigation and management of a raised serum ferritin. British Journal of Haematology. Volume181, Issue3. May 2018. Pages 331-340

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page